US Patent Issued to Shanghai Fosun Pharmaceutical Industrial Development on Nov. 4 for "Oxazole compound as multi-targeted inhibitor of IRAK4 and BTK" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,940, issued on Nov. 4, was assigned to Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. (Shanghai).

"Oxazole compound as multi-targeted inhibitor of IRAK4 and BTK" was invented by Jianfei Wang (Shanghai), Haizhong Tan (Shanghai), Jie Li (Shanghai), Yang Zhang (Shanghai), Jian Li (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a class of multi-targeted inhibitors of IRAK4 and BTK, and the use thereof in preparing a drug for treating IRAK4- and BTK-related diseases. The present invention specifically relates to the compounds represented by formula (II), isomers thereof or pharmaceutically ac...